Skip to main content
SpringerLink
Log in

Design, synthesis, evaluation and molecular modeling studies of some novel N-substituted piperidine-3-carboxylic acid derivatives as potential anticonvulsants

  • Original Research
  • Published:
Medicinal Chemistry Research Aims and scope Submit manuscript

Abstract

Novel Schiff bases of 1-(2-Aminoethyl)piperidine-3-carboxylic acid were synthesized, characterized and screened for anticonvulsant activity. Compounds were evaluated for in vitro blood–brain barrier (BBB) permeability by parallel artificial membrane permeability BBB assay (PAMPA-BBB). Compounds 5d, 5f, 5j, 5l, 5m, 5n, 5w, 5x and 5y elicited considerable in vitro permeability across BBB and further screened for in vivo anticonvulsant activity by sc-PTZ and DMCM-induced seizure models. The outcome of the in vivo models suggested that 5d, 5w, and 5y were most potent amongst the synthesized compounds. The neurotoxicity evaluation of 5d, 5w, and 5y by rotarod indicates no impairment of muscle coordination in comparison to standard diazepam. The MTT assay revealed that the test compounds (5d, 5w, and 5y) were not found to alter the cell viability considerably. In silico molecular docking and dynamics simulations were carried out on the homology modeled protein of human GABA transporter 1 (GAT1), which exhibited complementary interactions of compound 5w within the active binding pocket.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Scheme 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  • Ali FE, Bondinell WE, Dandridge PA, Frazee JS, Garvey E, Girard GR, Kaiser C, Ku TW, Lafferty JJ, Moonsammy GI (1985) Orally active and potent inhibitors of gamma-aminobutyric acid uptake. J Med Chem 28:653–660

    Article  CAS  PubMed  Google Scholar 

  • Aly MM, Mohamed YA, El-Bayouki KA, Basyouni WM, Abbas SY (2010) Synthesis of some new 4 (3H)-quinazolinone-2-carboxaldehyde thiosemicarbazones and their metal complexes and a study on their anticonvulsant, analgesic, cytotoxic and antimicrobial activities–Part-1. Eur J Med Chem 45:3365–3373

    Article  CAS  PubMed  Google Scholar 

  • Ambrósio AF, Silva AP, Araújo I, Malva JO, Soares-da-Silva Pc, Carvalho AP, Carvalho CM (2000) Neurotoxic/neuroprotective profile of carbamazepine, oxcarbazepine and two new putative antiepileptic drugs, BIA 2-093 and BIA 2-024. Eur J Pharmacol 406:191–201

    Article  PubMed  Google Scholar 

  • Andersen KE, Lau J, Lundt BF, Petersen H, Huusfeldt PO, Suzdak PD, Swedberg MD (2001a) Synthesis of novel GABA uptake inhibitors. Part 6: preparation and evaluation of N-Ω asymmetrically substituted nipecotic acid derivatives. Bioorg Med Chem 9:2773–2785

    Article  CAS  PubMed  Google Scholar 

  • Andersen KE, Sørensen JL, Lau J, Lundt BF, Petersen H, Huusfeldt PO, Suzdak PD, Swedberg MD (2001b) Synthesis of novel γ-aminobutyric acid (GABA) uptake inhibitors. 5. 1 Preparation and structure− activity studies of tricyclic analogues of known GABA uptake inhibitors. J Med Chem 44:2152–2163

    Article  CAS  PubMed  Google Scholar 

  • Araújo IM, Ambrósio AF, Leal EC, Verdasca MJ, Malva JO, Soares‐da‐Silva P, Carvalho AP, Carvalho CM (2004) Neurotoxicity induced by antiepileptic drugs in cultured hippocampal neurons: a comparative study between carbamazepine, oxcarbazepine, and two new putative antiepileptic drugs, BIA 2‐024 and BIA 2‐093. Epilepsia 45:1498–1505

    Article  PubMed  Google Scholar 

  • Banerjee AG, Das N, Shengule SA, Sharma PA, Srivastava RS, Shrivastava SK (2016) Design, synthesis, evaluation and molecular modelling studies of some novel 5, 6-diphenyl-1, 2, 4-triazin-3 (2H)-ones bearing five-member heterocyclic moieties as potential COX-2 inhibitors: a hybrid pharmacophore approach. Bioorg Chem 69:102–120

    Article  CAS  PubMed  Google Scholar 

  • Bhat MA, Al-Omar MA (2011) Synthesis, characterization and in vivo anticonvulsant and neurotoxicity screening of Schiff bases of phthalimide. Acta Pol Pharm 68:375–380

    CAS  PubMed  Google Scholar 

  • Bjorge S, Black A, Bockbrader H, Chang T, Gregor VE, Lobbestael SJ, Nugiel D, Pavia MR, Radulovic L, Woolf T (1990) Synthesis and metabolic profile of Cl‐966: a potent, orally‐active inhibitor of GABA uptake. Drug Dev Res 21:189–193

    Article  CAS  Google Scholar 

  • Braestrup C, Nielsen EB, Sonnewald U, Knutsen LJ, Andersen KE, Jansen JA, Frederiksen K, Andersen PH, Mortensen A, Suzdak PD (1990) R)‐N‐[4, 4‐Bis (3‐Methyl‐2‐Thienyl) but‐3‐en‐1‐yl] nipecotic acid binds with high affinity to the brain γ‐aminobutyric acid uptake carrier. J Neurochem 54:639–647

    Article  CAS  PubMed  Google Scholar 

  • Chen N-H, Reith ME, Quick MW (2004) Synaptic uptake and beyond: the sodium-and chloride-dependent neurotransmitter transporter family SLC6. Pflüg Arch 447:519–531

    Article  CAS  Google Scholar 

  • Das N, Garabadu D, Banerjee AG, Krishnamurthy S, Shrivastava SK (2014) Synthesis and pharmacological evaluation of some N3-aryl/heteroaryl-substituted 2-(2-chlorostyryl)-6, 7-dimethoxy-quinazolin-4 (3H)-ones as potential anticonvulsant agents. Med Chem Res 23:4167–4176

    Article  CAS  Google Scholar 

  • Dhar TM, Borden LA, Tyagarajan S, Smith KE, Branchek TA, Weinshank RL, Gluchowski C (1994) Design, synthesis and evaluation of substituted triarylnipecotic acid derivatives as GABA uptake inhibitors: identification of a ligand with moderate affinity and selectivity for the cloned human GABA transporter GAT-3. J Med Chem 37:2334–2342

    Article  CAS  PubMed  Google Scholar 

  • Di L, Kerns EH, Fan K, McConnell OJ, Carter GT (2003) High throughput artificial membrane permeability assay for blood–brain barrier. Eur J Med Chem 38:223–232

    Article  CAS  PubMed  Google Scholar 

  • El-Helby AGA, Ayyad RR, Sakr HM, Abdelrahim AS, El-Adl K, Sherbiny FS, Eissa IH, Khalifa MM (2017) Design, synthesis, molecular modeling and biological evaluation of novel 2, 3-dihydrophthalazine-1, 4-dione derivatives as potential anticonvulsant agents. J Mol Struct 1130:333–351

    Article  CAS  Google Scholar 

  • Falch E, Krogsgaard-Larsen P (1989) GABA uptake inhibitors containing mono-and diarylmethoxyalkyl N-substituents. Drug Des Deliv 4:205–215

    CAS  PubMed  Google Scholar 

  • Gao X-M, Chuang D-M (1992) Carbamazepine-induced neurotoxicity and its prevention by NMDA in cultured cerebellar granule cells. Neurosci Lett 135:159–162

    Article  CAS  PubMed  Google Scholar 

  • Gao X-M, Margolis RL, Leeds P, Hough C, Post RM, Chuang D-M (1995) Carbamazepine induction of apoptosis in cultured cerebellar neurons: effects ofN-methyl-d-aspartate, aurintricarboxylic acid and cycloheximide. Brain Res 703:63–71

    Article  CAS  PubMed  Google Scholar 

  • Ghadimi S, Latif Mousavi S, Javani Z (2008) Synthesis, lipophilicity study and in vitro evaluation of some rodenticides as acetylcholinesterase reversible inhibitors. J Enzyme Inhib Med Chem 23:213–217

    Article  CAS  PubMed  Google Scholar 

  • Ghareb N, Daim MMA, El-Sayed NM, Elgawish MS (2017) Synthesis, molecular modelling, and preliminary anticonvulsant activity evaluation of novel naphthalen-2-yl acetate and 1, 6-dithia-4, 9-diazaspiro [4.4] nonane-3, 8-dione derivatives. Bioorg Chem 71:110–119

    Article  CAS  PubMed  Google Scholar 

  • Holmes GL (1995) Role of glutamate and GABA in the pathophysiology of epilepsy. Dev Disabil Res Rev 1:208–219

    Google Scholar 

  • Jurik A, Reicherstorfer R, Zdrazil B, Ecker GF (2013) Classification of high‐activity tiagabine analogs by binary QSAR modeling. Mol Inform 32:415–419

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jurik A, Zdrazil B, Holy M, Stockner T, Sitte HH, Ecker GF (2015) A binding mode hypothesis of tiagabine confirms liothyronine effect on γ-aminobutyric acid transporter 1 (GAT1). J Med Chem 58:2149–2158

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kälviäinen R (2001) Long‐term safety of Tiagabine. Epilepsia 42:46–48

    Article  PubMed  Google Scholar 

  • Kim M, Cho AE (2016) Incorporating QM and solvation into docking for applications to GPCR targets. Phys Chem Chem Phys 18:28281–28289

    Article  CAS  PubMed  Google Scholar 

  • Kowalczyk P, Sałat K, Höfner GC, Mucha M, Rapacz A, Podkowa A, Filipek B, Wanner KT, Kulig K (2014) Synthesis, biological evaluation and structure–activity relationship of new GABA uptake inhibitors, derivatives of 4-aminobutanamides. Eur J Med Chem 83:256–273

    Article  CAS  PubMed  Google Scholar 

  • Krogsgaard-Larsen P (1980) Inhibitors of the GABA uptake systems. Mol Cell Biochem 31:105–121

    Article  CAS  PubMed  Google Scholar 

  • Krogsgaard‐Larsen P, Johnston G (1975) Inhibition of GABA uptake in rat brain slices by nipecotic acid, various isoxazoles and related compounds. J Neurochem 25:797–802

    Article  PubMed  Google Scholar 

  • Kulkarni A, Wankhede S, Dhawale N, Yadav P, Deore V, Gonjari I (2017) Synthesis, characterization and biological behavior of some Schiff’s and Mannich base derivatives of Lamotrigine. Arab J Chem 10:S184–S189

    Article  CAS  Google Scholar 

  • Lim S-W, Loh H-S, Ting K-N, Bradshaw TD, Allaudin ZN (2015) Reduction of MTT to purple formazan by vitamin E isomers in the absence of cells. Trop Life Sci Res 26:111

    PubMed  PubMed Central  Google Scholar 

  • Liu Y, Wang X-y, Li D, Yang L, Huang S-p (2015) Short-term use of antiepileptic drugs is neurotoxic to the immature brain. Neural Regen Res 10:599

    Article  PubMed  PubMed Central  Google Scholar 

  • Löscher W (1985) Anticonvulsant action in the epileptic gerbil of novel inhibitors of GABA uptake. Eur J Pharmacol 110:103–108

    Article  PubMed  Google Scholar 

  • Meena P, Nemaysh V, Khatri M, Manral A, Luthra PM, Tiwari M (2015) Synthesis, biological evaluation and molecular docking study of novel piperidine and piperazine derivatives as multi-targeted agents to treat Alzheimer’s disease. Bioorg Med Chem 23:1135–1148

    Article  CAS  PubMed  Google Scholar 

  • Murali Dhar T, Nagarathnam D, Marzabadi MR, Lagu B, Wong WC, Chiu G, Tyagarajan S, Miao SW, Zhang F, Sun W (1999) Design and synthesis of novel α1a adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety. J Med Chem 42:4778–4793

    Article  CAS  PubMed  Google Scholar 

  • Nielsen EB, Suzdak PD, Andersen KE, Knutsen LJ, Sonnewald U, Braestrup C (1991) Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitor. Eur J Pharmacol 196:257–266

    Article  CAS  PubMed  Google Scholar 

  • Nonaka S, Katsube N, Chuang D-M (1998) Lithium protects rat cerebellar granule cells against apoptosis induced by anticonvulsants, phenytoin and carbamazepine. J Pharmacol Exp Ther 286:539–547

    CAS  PubMed  Google Scholar 

  • Ortinski P, Meador KJ (2004) Cognitive side effects of antiepileptic drugs. Epilepsy Behav 5:60–65

    Article  Google Scholar 

  • Pandeya SN, Rajput N (2012) Synthesis and anticonvulsant activity of various Mannich and Schiff bases of 1,5-benzodiazepines. Int J Med Chem 2012:1–10

    Google Scholar 

  • Pavia MR, Lobbestael SJ, Nugiel D, Mayhugh DR, Gregor VE, Taylor CP, Schwarz RD, Brahce L, Vartanian MG (1992) Structure-activity studies on benzhydrol-containing nipecotic acid and guvacine derivatives as potent, orally-active inhibitors of GABA uptake. J Med Chem 35:4238–4248

    Article  CAS  PubMed  Google Scholar 

  • Petersen EN (1983) DMCM: a potent convulsive benzodiazepine receptor ligand. Eur J Pharmacol 94:117–124

    Article  CAS  PubMed  Google Scholar 

  • Petrera M, Wein T, Allmendinger L, Sindelar M, Pabel J, Höfner G, Wanner KT (2016) Development of highly potent GAT1 inhibitors: synthesis of nipecotic acid derivatives by Suzuki–Miyaura cross‐coupling reactions. ChemMedChem 11:519–538

    Article  CAS  PubMed  Google Scholar 

  • Petroff OA, Rothman DL, Behar KL, Mattson RH (1996) Low brain GABA level is associated with poor seizure control. Ann Neurol 40:908–911

    Article  CAS  PubMed  Google Scholar 

  • Prescott L (1997) Tiagabine offers effective seizure control. Inpharma Wkly 1085:15–16

    Google Scholar 

  • Quandt G, Höfner G, Wanner KT (2013) Synthesis and evaluation of N-substituted nipecotic acid derivatives with an unsymmetrical bis-aromatic residue attached to a vinyl ether spacer as potential GABA uptake inhibitors. Bioorg Med Chem 21:3363–3378

    Article  CAS  PubMed  Google Scholar 

  • Regulska M, Pomierny B, Basta-Kaim A, Starek A, Filip M, Lasoń W, Budziszewska B (2010) Effects of ethylene glycol ethers on cell viability in the human neuroblastoma SH-SY5Y cell line. Pharmacol Rep 62:1243–1249

    Article  CAS  PubMed  Google Scholar 

  • Shidore M, Machhi J, Shingala K, Murumkar P, Sharma MK, Agrawal N, Tripathi A, Parikh Z, Pillai P, Yadav MR (2016) Benzylpiperidine-linked Diarylthiazoles as potential anti-Alzheimer’s agents: synthesis and biological evaluation. J Med Chem 59:5823–5846

    Article  CAS  PubMed  Google Scholar 

  • Siddiqui N, Alam MS, Sahu M, Naim MJ, Yar MS, Alam O (2017) Design, synthesis, anticonvulsant evaluation and docking study of 2-[(6-substituted benzo [d] thiazol-2-ylcarbamoyl) methyl]-1-(4-substituted phenyl) isothioureas. Bioorg Chem 71:230–243

    Article  CAS  PubMed  Google Scholar 

  • Singh RB, Singh GK, Chaturvedi K, Kumar D, Singh SK, Zaman MK (2017) Design, synthesis, characterization, and molecular modeling studies of novel oxadiazole derivatives of nipecotic acid as potential anticonvulsant and antidepressant agents. Med Chem Res 27:137–152

    Article  Google Scholar 

  • Skovstrup S, Taboureau O, Bräuner‐Osborne H, Jørgensen FS (2010) Homology modelling of the GABA transporter and analysis of tiagabine binding. ChemMedChem 5:986–1000

    Article  CAS  PubMed  Google Scholar 

  • Suzdak PD, Jansen JA (1995) A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor. Epilepsia 36:612–626

    Article  CAS  PubMed  Google Scholar 

  • Sveinbjornsdottir S, Sander J, Patsalos P, Upton D, Thompson P, Duncan J (1994) Neuropsychological effects of tiagabine, a potential new antiepileptic drug. Seizure 3:29–35

    Article  CAS  PubMed  Google Scholar 

  • Swathi K, Sarangapani M (2015) Synthesis and antiepileptic activity of Schiff’s bases of dialkylamino alkoxy isatin derivatives. GeNeDis 2014. Springer International Publishing, Swizerland

  • Taylor CP, Vartanian MG, Schwarz RD, Rock DM, Callahan MJ, Davis MD (1990) Pharmacology of Cl‐966: A potent GABA uptake inhibitor, in vitro and in experimental animals. Drug Dev Res 21:195–215

    Article  CAS  Google Scholar 

  • Thompson SM, Gahwiler B (1992) Effects of the GABA uptake inhibitor tiagabine on inhibitory synaptic potentials in rat hippocampal slice cultures. J Neurophysiol 67:1698–1701

    Article  CAS  PubMed  Google Scholar 

  • Villalba ML, Enrique AV, Higgs J, Castaño RA, Goicoechea S, Taborda FD, Gavernet L, Lick ID, Marder M, Blanch LEB (2016) Novel sulfamides and sulfamates derived from amino esters: synthetic studies and anticonvulsant activity. Eur J Pharmacol 774:55–63

    Article  CAS  PubMed  Google Scholar 

  • Wang KH, Penmatsa A, Gouaux E (2015) Neurotransmitter and psychostimulant recognition by the dopamine transporter. Nature 521:322–327

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yunger L, Fowler P, Zarevics P, Setler P (1984) Novel inhibitors of gamma-aminobutyric acid (GABA) uptake: anticonvulsant actions in rats and mice. J Pharmacol Exp Ther 228:109–115

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharmaceutical Chemistry Research Laboratory, Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi, 221005, India

    Ankit Seth, Piyoosh A. Sharma, Avanish Tripathi, Priyanka K. Choubey, Pavan Srivastava, Prabhash Nath Tripathi & Sushant Kumar Shrivastava

Authors
  1. Ankit Seth
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Piyoosh A. Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Avanish Tripathi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Priyanka K. Choubey
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Pavan Srivastava
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Prabhash Nath Tripathi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sushant Kumar Shrivastava
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sushant Kumar Shrivastava.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Seth, A., Sharma, P.A., Tripathi, A. et al. Design, synthesis, evaluation and molecular modeling studies of some novel N-substituted piperidine-3-carboxylic acid derivatives as potential anticonvulsants. Med Chem Res 27, 1206–1225 (2018). https://doi.org/10.1007/s00044-018-2141-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00044-018-2141-9

Keywords

Search

Navigation